About: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study
Creator	Carugati, Manuela Blasi, F Aliberti, S Battaglia, & Collaborators, Glimp Encheva, & Fantini, & Gallego, & Gori, & Leuschner, & Marin-Corral, & Menendez, & Pascual-Guardia, & Restrepo, & Ruiz-Buitrago, & Sotgiu, &
Source	PMC
abstract	An accurate knowledge of the epidemiology of community-acquired pneumonia (CAP) is key for selecting appropriate antimicrobial treatments. Very few etiological studies assessed the appropriateness of empiric guideline recommendations at a multinational level. This study aims at the following: (i) describing the bacterial etiologic distribution of CAP and (ii) assessing the appropriateness of the empirical treatment recommendations by clinical practice guidelines (CPGs) for CAP in light of the bacterial pathogens diagnosed as causative agents of CAP. Secondary analysis of the GLIMP, a point-prevalence international study which enrolled adults hospitalized with CAP in 2015. The analysis was limited to immunocompetent patients tested for bacterial CAP agents within 24 h of admission. The CAP CPGs evaluated included the following: the 2007 and 2019 American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA), the European Respiratory Society (ERS), and selected country-specific CPGs. Among 2564 patients enrolled, 35.3% had an identifiable pathogen. Streptococcus pneumoniae (8.2%) was the most frequently identified pathogen, followed by Pseudomonas aeruginosa (4.1%) and Klebsiella pneumoniae (3.4%). CPGs appropriately recommend covering more than 90% of all the potential pathogens causing CAP, with the exception of patients enrolled from Germany, Pakistan, and Croatia. The 2019 ATS/IDSA CPGs appropriately recommend covering 93.6% of the cases compared with 90.3% of the ERS CPGs (p < 0.01). S. pneumoniae remains the most common pathogen in patients hospitalized with CAP. Multinational CPG recommendations for patients with CAP seem to appropriately cover the most common pathogens and should be strongly encouraged for the management of CAP patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10096-020-03870-3) contains supplementary material, which is available to authorized users.
has issue date	2020-04-03(xsd:dateTime)
bibo:doi	10.1007/s10096-020-03870-3
bibo:pmid	32242314
has license	no-cc
sha1sum (hex)	3139cba3c03b1c426ba1f9bf83113c5745cc7e12
schema:url	https://doi.org/10.1007/s10096-020-03870-3
resource representing a document's title	Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study
has PubMed Central identifier	PMC7222990
has PubMed identifier	32242314
schema:publication	Eur J Clin Microbiol Infect Dis
resource representing a document's body	covid:3139cba3c03b1c426ba1f9bf83113c5745cc7e12#body_text
is schema:about of	named entity 'Secondary' named entity 'empirical treatment' named entity 'empirical treatment' named entity 'A POINT' named entity 'EMPIRIC' named entity 'LIGHT' named entity 'describing' named entity 'agents' named entity 'aims' named entity 'CAP' named entity 'empiric' named entity 'CPGs' named entity 'CAP' named entity 'bacterial pathogens' named entity 'CAP' named entity 'CAP' named entity 'CAP' named entity 'epidemiology' named entity 'community-acquired pneumonia' named entity 'clinical practice guidelines' named entity 'CPGs' named entity 'β-lactam' named entity 'P. aeruginosa' named entity 'MRSA' named entity 'P. aeruginosa' named entity 'MRSA' named entity 'white blood cell count' named entity 'Armonk' named entity 'CD4+ lymphocyte' named entity 'multiple myeloma' named entity 'S. pneumoniae' named entity 'human immunodeficiency virus infection' named entity 'pleural fluid' named entity 'CPGs' named entity 'BTS' named entity 'ERS' named entity 'IDSA' named entity 'CAP' named entity 'external validity' named entity 'MRSA' named entity 'bacteria' named entity 'neutrophil' named entity 'doxycycline' named entity 'ICU' named entity 'ICU' named entity 'β-lactam' named entity 'adverse events' named entity 'ERS' named entity 'CAP' named entity 'pneumococcus' named entity 'asplenia' named entity 'CAP' named entity 'bacteria' named entity 'risk factors' named entity 'GLIMP' named entity 'pathogens' named entity 'empirical treatment' named entity 'CAP' named entity 'Croatia' named entity 'risk factors' named entity 'tertiary care' named entity 'Medicare' named entity 'ERS' named entity 'CAP' named entity '2.6 million' named entity 'prednisone'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software